Canagliflozin | Teneligliptin | |||||
---|---|---|---|---|---|---|
Baseline | 24 weeks | p | Baseline | 24 weeks | p | |
HbA1c (%), mean ± SD | 7.7 ± 0.6 | 7.0 ± 0.6 | < 0.0001 | 7.8 ± 0.8 | 7.2 ± 0.7 | < 0.0001 |
HOMA-IR, mean ± SD | 4.9 ± 6.1 | 3.5 ± 6.4 | < 0.0001 | 4.0 ± 3.6 | 3.7 ± 2.8 | 0.2451 |
Ketone body (µmol/L), mean ± SD | 110.0 ± 113.8 | 206.4 ± 186.3 | < 0.0001 | 110.2 ± 94 | 109.8 ± 80.3 | 0.7946 |
Body weight (kg), mean ± SD | 79.0 ± 15.2 | 76.6 ± 15.2 | < 0.0001 | 79.2 ± 16.7 | 79.1 ± 16.4 | 0.0899 |
Ht (%), mean ± SD | 44.6 ± 3.5 | 47.2 ± 3.5 | < 0.0001 | 44.9 ± 4.0 | 44.9 ± 4.3 | 0.7740 |
Energy intake (kcal/day), mean ± SD | 1747.7 ± 634.3 | 1859.7 ± 639.8 | 0.0872 | 1789 ± 601.7 | 1620.9 ± 516.9 | 0.0354 |
Protein intake (g/day), mean ± SD | 66.1 ± 26.9 | 69.9 ± 29.1 | 0.1032 | 67.8 ± 28.4 | 64.3 ± 26.1 | 0.2634 |
Fat intake (g/day), mean ± SD | 50.1 ± 18.4 | 53.1 ± 19.0 | 0.1355 | 54.4 ± 23.2 | 47.9 ± 19.3 | 0.0105 |
Carbohydrate intake (g/day), mean ± SD | 216 ± 73.2 | 236.5 ± 83.8 | 0.1072 | 230.1 ± 90.8 | 209.7 ± 75.8 | 0.1632 |
Sucrose intake (g/day), mean ± SD | 7.8 ± 6.2 | 8.7 ± 6.6 | 0.0889 | 9.0 ± 7.4 | 8.3 ± 6.0 | 0.8843 |
AST (IU/L), mean ± SD | 32.1 ± 19.7 | 25.5 ± 12.0 | < 0.0001 | 30.3 ± 17.7 | 30.6 ± 20.5 | 0.9764 |
ALT (IU/L), mean ± SD | 40.4 ± 28.0 | 30.1 ± 19.6 | < 0.0001 | 41.1 ± 33.1 | 40.4 ± 36.0 | 0.4180 |
γ-GTP (IU/L), mean ± SD | 67.6 ± 96.9 | 47.4 ± 43.9 | < 0.0001 | 54.3 ± 52.6 | 51.8 ± 51.3 | 0.2547 |
Fib 4 index, mean ± SD | 1.3 ± 0.8 | 1.2 ± 0.6 | 0.1047 | 1.2 ± 0.6 | 1.2 ± 0.7 | 0.2362 |